A New Dawn for Adult Hearing impairment Treatment in France

The Adolphe de Rothschild Foundation Hospital has announced the inauguration of its Cochlear and Auditory Adult Implant Expertise center (CEICA), marking a important advancement in the treatment of severe hearing loss. This pioneering initiative, the first of its kind within a private, non-profit hospital in France, aims to provide comprehensive and personalized care for adults with profound hearing impairment.

National Recognition and Enhanced Otological Services

Following its designation as a Cochlear Adult Reference Center by the Ministry of Health in May 2024, the Adolphe de Rothschild Foundation Hospital has solidified its commitment to audiological excellence with the establishment of the CEICA in early 2025. Integrated within the hospital’s well-established ENT (Ear, Nose, and Throat) department, the center considerably expands the hospital’s already robust medical and surgical capabilities in otology. The CEICA offers a specialized care pathway meticulously designed to provide multidisciplinary therapeutic support for individuals with severe to profound hearing loss who are candidates for cochlear implantation,and also ongoing monitoring for those who have already received implants.

Personalized Care and Improved Quality of Life

The CEICA is committed to delivering a streamlined and individualized care experience. The center’s primary objective is to actively engage patients in their cochlear implant journey, empowering them to achieve a significantly improved quality of life within a reasonable timeframe. This patient-centric approach is built upon several key pillars:

• Expert Multidisciplinary Team: A dedicated team of audiologists,surgeons,therapists,and support staff collaborate to provide comprehensive care.
• Personalized Follow-Up: Each patient receives tailored support and monitoring throughout their treatment.
• Continuum of Care: The center provides ongoing support for implanted children transitioning into adulthood, ensuring seamless care throughout their lives.
• collaboration with patient Associations: Working closely with patient advocacy groups to provide resources and support networks.
• City-Hospital Network Development: Establishing strong partnerships with community healthcare providers to ensure accessible and coordinated care.
• Multi-Brand care: Offering expertise and support for various cochlear implant brands, ensuring patients receive the most appropriate technology for their needs.

Innovation and Quality at the Forefront

The launch of the CEICA underscores the Adolphe de Rothschild Foundation Hospital’s dedication to excellence, placing innovation and superior care at the core of its mission. The center’s modern, renovated facilities provide a comfortable surroundings for patients and foster the development of clinical research projects aimed at continuously refining and improving the specialized care pathway for individuals with hearing disorders.

According to the World Health Organization (WHO), over 5% of the world’s population – or 430 million people – requires rehabilitation to address their ‘disabling’ hearing loss (360 million adults and 34 million children). Cochlear implants represent a significant intervention for many of these individuals, offering the potential to restore hearing and improve communication abilities.

“The CEICA is a testament to our commitment to providing cutting-edge care and improving the lives of individuals with hearing loss.”

– A spokesperson for the Adolphe de Rothschild Foundation Hospital